To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene GPR176andFSIP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
162 supporting clones for gene GPR176andFSIP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX642685   .a 1 to 479 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
BX642686   .a 1 to 579 1 to 579   tiling clone,   579/579
(100 %)
1 diff
(99.9 %id)
NM_152597.4   .a 2 to 2814 1 to 2813 exact RefSeq,   2813/2813
(100 %)
0 diff
(100 %id)
BI561990 testis .a 5 to 634 1 to 632       632/633
(99 %)
12 diff
(98.2 %id)
BC045191 testis .a 10 to 2812 1 to 2803 R354H C402R tiling clone, available from MGC, AAA   2803/2803
(100 %)
5 diff
(99.9 %id)
TI_44349899   .a 10 to 634 117 to 743       627/744
(84 %)
12 diff
(98.4 %id)
DA170495 amygdala .a 11 to 542 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DN992230 brain, whole brain .a 19 to 509 1 to 491       491/491
(100 %)
5 diff
(99.0 %id)
AK093308 testis .a 20 to 2052 1 to 2033 exact tiling clone, available from FLJ,   2033/2033
(100 %)
1 diff
(100.0 %id)
AX748045   .a 20 to 2052 1 to 2033 exact     2033/2033
(100 %)
1 diff
(100.0 %id)
DB030649 testis .a 21 to 604 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA708768   .a 70 to 622 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
AY260140 testis .a 205 to 1979 1 to 1775 S75R A574G     1775/1775
(100 %)
2 diff
(99.9 %id)
TI_1948157018   .a 215 to 1111 132 to 1027       896/1356
(66 %)
11 diff
(99.2 %id)
TI_1948157167   .a 215 to 1111 133 to 1026       894/1395
(64 %)
25 diff
(98.3 %id)
TI_1948157330   .a 215 to 1314 133 to 1222       1092/1356
(80 %)
30 diff
(97.8 %id)
TI_1948207495   .a 215 to 1179 130 to 1084   fully sequenced,   955/1084
(88 %)
18 diff
(98.4 %id)
EL733899 mixed .a 220 to 827 1 to 608       608/608
(100 %)
0 diff
(100 %id)
TI_1948157019   .a 1122 to 1968 971 to 122       850/1226
(69 %)
7 diff
(99.5 %id)
TI_1948207496   .a 1149 to 1968 946 to 122   fully sequenced,   825/946
(87 %)
12 diff
(98.8 %id)
DA569654 whole embryo, mainly head .a 1314 to 2170 2 to 857   capped   856/856
(100 %)
6 diff
(99.3 %id)
TI_1948157331   .a 1403 to 1968 689 to 123       567/1229
(46 %)
4 diff
(99.7 %id)
FN141152 breast carcinoma .a 1413 to 1469 1 to 57       57/58
(98 %)
4 diff
(93.2 %id)
FN062133 breast carcinoma .a 1431 to 1535 1 to 105       105/105
(100 %)
4 diff
(96.2 %id)
DB337001 testis .a 1503 to 2052 551 to 1       551/551
(100 %)
1 diff
(99.9 %id)
FN072513 breast carcinoma .a 1512 to 1568 56 to 1     Submitted on the opposite strand 56/57
(98 %)
1 diff
(98.3 %id)
BX118373 breast .a 1514 to 2189 1 to 676   AAA   676/676
(100 %)
0 diff
(100 %id)
AI792054 breast .a 1514 to 1978 1 to 465       465/465
(100 %)
0 diff
(100 %id)
FN093150 breast carcinoma .a 1519 to 1576 1 to 59       59/60
(98 %)
2 diff
(96.7 %id)
FN144247 breast carcinoma .a 1595 to 1690 1 to 96       96/96
(100 %)
0 diff
(100 %id)
FN074328 breast carcinoma .a 1620 to 1687 68 to 2     Submitted on the opposite strand 67/76
(88 %)
0 diff
(100 %id)
BX281144 testis .a 1638 to 2038 429 to 29   AAA Submitted on the opposite strand 401/401
(100 %)
0 diff
(100 %id)
AI820662 breast .a 1690 to 2190 501 to 1       501/501
(100 %)
0 diff
(100 %id)
FN169834 breast carcinoma .a 1708 to 1811 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
FN156177 breast carcinoma .a 1731 to 1842 111 to 1     Submitted on the opposite strand 111/111
(100 %)
4 diff
(96.4 %id)
FN075258 breast carcinoma .a 1781 to 1879 1 to 99       99/99
(100 %)
0 diff
(100 %id)
AA996091 breast .a 1835 to 2189 355 to 1       355/355
(100 %)
1 diff
(99.8 %id)
FN141857 breast carcinoma .a 2027 to 2123 95 to 1     Submitted on the opposite strand 95/95
(100 %)
4 diff
(95.8 %id)
AI813295 2 pooled tumors (clear cell type), Kidney .a 2157 to 2623 469 to 5       465/469
(99 %)
0 diff
(100 %id)
FN156907 breast carcinoma .a 2211 to 2319 106 to 1     Submitted on the opposite strand 106/106
(100 %)
3 diff
(97.2 %id)
DB356339 whole embryo, mainly head .a 2217 to 2808 591 to 1   tiling clone,   591/593
(99 %)
22 diff
(96.3 %id)
FN063113 breast carcinoma .a 2282 to 2376 1 to 92       92/92
(100 %)
4 diff
(95.7 %id)
FN048916 breast carcinoma .a 2394 to 2486 93 to 1     Submitted on the opposite strand 93/95
(97 %)
1 diff
(99.0 %id)
FN146729 breast carcinoma .a 2430 to 2530 101 to 3     Submitted on the opposite strand 99/105
(94 %)
0 diff
(100 %id)
FN123869 breast carcinoma .a 2439 to 2532 92 to 1     Submitted on the opposite strand 92/93
(98 %)
6 diff
(93.6 %id)
FN148435 breast carcinoma .a 2439 to 2532 92 to 1     Submitted on the opposite strand 92/93
(98 %)
2 diff
(97.9 %id)
EC461156 Prostate .a 2649 to 2745 1 to 96       96/100
(96 %)
2 diff
(98.0 %id)
FN157831 breast carcinoma .a 2666 to 2763 1 to 96       96/97
(98 %)
3 diff
(97.0 %id)
FN113796 breast carcinoma .a 2667 to 2763 1 to 94       94/94
(100 %)
4 diff
(95.8 %id)
BC067106 Ovary, teratocarcinoma .b 1 to 3838 1 to 3846 K143R tiling clone, available from MGC, AAA   3846/3846
(100 %)
7 diff
(99.9 %id)
BU844486 ovary, teratocarcinoma, cell line .b 2 to 859 1 to 864       864/906
(95 %)
16 diff
(98.3 %id)
BU844492 ovary, teratocarcinoma, cell line .b 2 to 834 1 to 840       840/895
(93 %)
19 diff
(97.9 %id)
BU556532 ovary, teratocarcinoma, cell line .b 2 to 806 1 to 810       810/996
(81 %)
12 diff
(98.8 %id)
BU849195 ovary, teratocarcinoma, cell line .b 2 to 851 1 to 859       859/925
(92 %)
20 diff
(97.9 %id)
BU856085 ovary, teratocarcinoma, cell line .b 2 to 701 1 to 710       710/976
(72 %)
23 diff
(97.7 %id)
TI_1948225748   .b 199 to 1041 127 to 986   fully sequenced,   860/986
(87 %)
25 diff
(97.5 %id)
TI_1948225889   .b 199 to 892 125 to 831   fully sequenced,   707/831
(85 %)
23 diff
(97.3 %id)
TI_1948226038   .b 199 to 1103 121 to 1027   fully sequenced,   907/1027
(88 %)
35 diff
(96.6 %id)
EL736137 mixed .b 200 to 818 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
BG327935 Kidney, renal cell adenocarcinoma .b 435 to 1135 1 to 696       696/696
(100 %)
16 diff
(97.8 %id)
CN408699 embryonic stem cells, cell lines H1, H7, andH9 .b 449 to 1010 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
CD652569 Embryonic Stem cells .b 556 to 1394 12 to 844       833/844
(98 %)
21 diff
(97.6 %id)
BX370443   .b 670 to 1605 1 to 940   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 940/972
(96 %)
73 diff
(92.5 %id)
CO248183 Chondrosarcoma Lung Metastasis cell lines, lung .b 771 to 1468 23 to 706       684/781
(87 %)
19 diff
(97.6 %id)
AA323608 brain, cerebellum .b 779 to 973 1 to 195       195/195
(100 %)
0 diff
(100 %id)
CX163734 human embryonic stem cells differentiated toan early endodermal cell type .b 816 to 1649 18 to 851       834/851
(98 %)
6 diff
(99.3 %id)
TI_1948225890   .b 862 to 1752 1002 to 113   fully sequenced,   890/1002
(88 %)
28 diff
(97.3 %id)
TI_1948225749   .b 1011 to 1752 871 to 115   fully sequenced,   757/871
(86 %)
7 diff
(99.2 %id)
TI_1948226039   .b 1073 to 1752 798 to 115   fully sequenced,   684/798
(85 %)
8 diff
(99.0 %id)
CA429400 Cell Line, Chondrosarcoma .b 1131 to 1731 617 to 16   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 602/617
(97 %)
0 diff
(100 %id)
BG167724 hypernephroma, cell line, Kidney .b 1138 to 1591 1 to 456       456/457
(99 %)
5 diff
(99.0 %id)
CN408702 embryonic stem cells, cell lines H1, H7, andH9 .b 1282 to 1929 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
BG750442 eye, normal pigmented retinal epithelium .b 1314 to 2084 1 to 770       770/770
(100 %)
6 diff
(99.3 %id)
BG385760 adenocarcinoma cell line, colon .b 1357 to 2066 1 to 742       742/746
(99 %)
35 diff
(95.4 %id)
CF619313 Pooled Chondrosarcoma Tumor cells .b 1375 to 2205 1 to 835       835/835
(100 %)
11 diff
(98.7 %id)
CK000364 mixed .b 1535 to 2308 8 to 781       774/786
(98 %)
3 diff
(99.7 %id)
BE274653 melanotic melanoma, skin .b 1563 to 2379 1 to 805       805/808
(99 %)
31 diff
(96.2 %id)
BE746288 adenocarcinoma cell line, ovary .b 1591 to 2395 1 to 810       810/1128
(71 %)
23 diff
(98.0 %id)
CX786330 human embryonic stem cells .b 1650 to 2433 1 to 783       783/783
(100 %)
2 diff
(99.8 %id)
BG325835 Kidney, renal cell adenocarcinoma .b 1659 to 2171 1 to 514       514/514
(100 %)
4 diff
(99.3 %id)
BG253001 adenocarcinoma, cell line, Liver .b 1677 to 2364 1 to 696       696/917
(75 %)
22 diff
(97.7 %id)
BI195690 brain, neuroblastoma .b 1680 to 2388 1 to 709       709/709
(100 %)
5 diff
(99.3 %id)
CN408697 embryonic stem cells, cell lines H1, H7, andH9 .b 1769 to 2438 1 to 670       670/670
(100 %)
3 diff
(99.6 %id)
BM546839 ovary (pool of 3) .b 1805 to 2801 24 to 1028       1005/1056
(95 %)
19 diff
(98.3 %id)
BM011585 brain, neuroblastoma, cell line .b 1939 to 2566 1 to 635       635/635
(100 %)
18 diff
(97.2 %id)
TI_59380754   .b 1940 to 2566 61 to 694       634/634
(100 %)
18 diff
(97.2 %id)
CX785268 human embryonic stem cells .b 1942 to 2806 1 to 864       864/864
(100 %)
2 diff
(99.8 %id)
BG119255 adenocarcinoma, cell line, Liver .b 1959 to 2681 1 to 720       720/985
(73 %)
16 diff
(98.4 %id)
BI457187 epithelioid carcinoma cell line, Pancreas .b 1986 to 2697 1 to 712       712/735
(96 %)
12 diff
(98.4 %id)
TI_45133427   .b 1987 to 2697 58 to 768       711/734
(96 %)
12 diff
(98.4 %id)
TI_44169451   .b 1996 to 2682 81 to 771       691/888
(77 %)
6 diff
(99.4 %id)
BI550244 brain, hippocampus .b 1998 to 2682 1 to 689       689/806
(85 %)
9 diff
(98.9 %id)
BU521504 leiomyosarcoma, uterus .b 2162 to 3044 1 to 890   tiling clone,   890/890
(100 %)
18 diff
(98.0 %id)
BM043739 carcinoma, cell line, Prostate .b 2242 to 2950 1 to 725       725/799
(90 %)
28 diff
(96.5 %id)
BU542589 carcinoma, cell line, Prostate .b 2244 to 3081 1 to 846       846/927
(91 %)
22 diff
(97.7 %id)
BU552614 carcinoma, cell line, Prostate .b 2245 to 3143 1 to 904       904/909
(99 %)
11 diff
(98.8 %id)
CR605597 fetal brain .b 2252 to 3705 1 to 1454       1454/1454
(100 %)
0 diff
(100 %id)
AL537814 brain, fetal brain .b 2252 to 3192 1 to 928   fully sequenced,   928/928
(100 %)
4 diff
(99.6 %id)
CX782105 human embryonic stem cells .b 2287 to 3087 1 to 801       801/801
(100 %)
0 diff
(100 %id)
AA644153 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2389 to 2886 500 to 3       498/500
(99 %)
0 diff
(100 %id)
BX350470   .b 2413 to 2927 546 to 29       518/648
(79 %)
0 diff
(100 %id)
BQ948108 epidermoid carcinoma, cell line, lung .b 2433 to 3265 1 to 846       846/981
(86 %)
39 diff
(96.1 %id)
BQ948745 epidermoid carcinoma, cell line, lung .b 2433 to 3364 1 to 933       933/936
(99 %)
27 diff
(97.2 %id)
BQ933177 sciatic nerve .b 2480 to 3403 1 to 937       937/937
(100 %)
25 diff
(97.4 %id)
BG422352 Kidney, renal cell adenocarcinoma .b 2517 to 3250 1 to 725       725/742
(97 %)
19 diff
(97.5 %id)
BG118196 adenocarcinoma, cell line, Liver .b 2522 to 3275 1 to 744       744/979
(75 %)
34 diff
(96.6 %id)
AI351032   .b 2532 to 2886 359 to 5       355/359
(98 %)
0 diff
(100 %id)
CA431144 cell lines, Chondrosarcoma .b 2592 to 3227 1 to 638     Submitted on the opposite strand 638/638
(100 %)
4 diff
(99.4 %id)
R15616   .b 2608 to 2796 1 to 189       189/189
(100 %)
7 diff
(96.3 %id)
BF955403 nervous_normal .b 2619 to 3001 388 to 4       385/406
(94 %)
8 diff
(98.1 %id)
CX781367 human embryonic stem cells .b 2652 to 3508 1 to 857       857/857
(100 %)
3 diff
(99.7 %id)
AL578799 placenta .b 2702 to 3703 996 to 1       996/1049
(94 %)
16 diff
(98.5 %id)
BE149438 head_neck .b 2736 to 3424 1 to 683       683/685
(99 %)
22 diff
(96.8 %id)
BG118720 adenocarcinoma, cell line, Liver .b 2833 to 3680 1 to 860       860/893
(96 %)
36 diff
(96.0 %id)
BF337040 brain, glioblastoma with EGFR amplification .b 2897 to 3678 53 to 836       784/1024
(76 %)
22 diff
(97.9 %id)
BU902189 leiomyosarcoma, uterus .b 2916 to 3733 1 to 819   AAA   819/819
(100 %)
1 diff
(99.9 %id)
AL118585 amygdala .b 2953 to 3655 1 to 706       706/710
(99 %)
4 diff
(99.5 %id)
W24047 senescent fibroblast .b 2961 to 3310 1 to 355   fully sequenced,   355/355
(100 %)
11 diff
(97.0 %id)
BU629867 cell lines, Chondrosarcoma .b 3016 to 3733 732 to 19   AAA   714/714
(100 %)
4 diff
(99.5 %id)
AL567010 brain, fetal brain .b 3162 to 3705 533 to 1   fully sequenced,   533/533
(100 %)
1 diff
(99.9 %id)
AA526584 normal prostate, Prostate .b 3225 to 3733 510 to 1       510/516
(98 %)
54 diff
(89.6 %id)
BQ226412 embryonal carcinoma, cell line, testis .b 3271 to 3865 8 to 606       599/922
(64 %)
17 diff
(98.2 %id)
N95435 senescent fibroblast .b 3280 to 3736 454 to 1   fully sequenced,   454/454
(100 %)
4 diff
(99.2 %id)
AW007995 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3310 to 3736 432 to 4       429/432
(99 %)
0 diff
(100 %id)
AW518975 adenocarcinoma, Pancreas .b 3313 to 3735 428 to 6       423/428
(98 %)
0 diff
(100 %id)
AI653459 ovary, tumor, 5 pooled (see description) .b 3322 to 3733 448 to 36   AAA   413/413
(100 %)
19 diff
(95.4 %id)
BQ017829 Chondrosarcoma, Left Pubic Bone .b 3338 to 3713 1 to 377     Submitted on the opposite strand 377/377
(100 %)
16 diff
(95.8 %id)
BQ446854 Knee, Osteoarthritic Cartilage .b 3340 to 3733 3 to 396   AAA Submitted on the opposite strand 394/396
(99 %)
6 diff
(98.5 %id)
BG152859 Prostate .b 3380 to 3735 358 to 3       356/358
(99 %)
0 diff
(100 %id)
AW804897 uterus .b 3454 to 3664 8 to 219       212/219
(96 %)
6 diff
(97.3 %id)
AA865239 2 pooled tumors (clear cell type), Kidney .b 3456 to 3854 401 to 3   tiling clone,   399/401
(99 %)
0 diff
(100 %id)
AI811992 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3465 to 3733 287 to 19   AAA   269/269
(100 %)
2 diff
(99.3 %id)
AI364485 anaplastic oligodendroglioma, brain .b 3466 to 3736 293 to 23       271/293
(92 %)
0 diff
(100 %id)
AI364318 anaplastic oligodendroglioma, brain .b 3530 to 3736 239 to 33       207/239
(86 %)
0 diff
(100 %id)
CB106487 Liver .b 3661 to 3854 1 to 194       194/212
(91 %)
1 diff
(99.6 %id)
DB454312 testis .c 1 to 455 1 to 455   tiling clone,   455/455
(100 %)
2 diff
(99.6 %id)
CD623932   .c 34 to 678 646 to 7       640/647
(98 %)
0 diff
(100 %id)
D38449 brain .c 41 to 2856 1 to 2816 exact tiling clone,   2816/2816
(100 %)
1 diff
(100.0 %id)
NM_007223.1   .c 41 to 2856 1 to 2816 exact RefSeq,   2816/2816
(100 %)
1 diff
(100.0 %id)
CD623930   .c 42 to 687 645 to 1       645/719
(89 %)
10 diff
(98.7 %id)
CD623934   .c 42 to 684 636 to 1       636/642
(99 %)
21 diff
(96.8 %id)
CD623931   .c 45 to 644 1 to 602       602/604
(99 %)
8 diff
(98.7 %id)
CD623933   .c 45 to 673 1 to 633       633/637
(99 %)
6 diff
(99.1 %id)
CD623935   .c 45 to 673 1 to 630       630/630
(100 %)
3 diff
(99.6 %id)
CD623936   .c 45 to 663 1 to 617       617/618
(99 %)
11 diff
(98.3 %id)
CD623941   .c 45 to 688 1 to 646       646/647
(99 %)
7 diff
(99.0 %id)
DA104561 cerebellum .c 79 to 633 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
CD623937   .c 92 to 686 596 to 1       596/596
(100 %)
4 diff
(99.4 %id)
CD623940   .c 93 to 688 597 to 1       597/597
(100 %)
15 diff
(97.5 %id)
DR002570 fetal brain .c 115 to 753 1 to 640       640/640
(100 %)
7 diff
(99.0 %id)
CN408700 embryonic stem cells, cell lines H1, H7, andH9 .c 267 to 450 1 to 184       184/184
(100 %)
0 diff
(100 %id)
CD623938   .c 480 to 685 206 to 1       206/215
(95 %)
1 diff
(99.6 %id)
CD623939   .c 480 to 688 10 to 219       210/220
(95 %)
3 diff
(98.7 %id)
CN408696 embryonic stem cells, cell lines H1, H7, andH9 .c 706 to 1252 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
BU553079 ovary, teratocarcinoma, cell line .c 709 to 1078 1 to 370       370/858
(43 %)
1 diff
(99.9 %id)
DY320183 mixed .c 756 to 1082 1 to 327       327/703
(46 %)
3 diff
(99.6 %id)
CN408701 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 781 to 1324 1 to 543       543/543
(100 %)
2 diff
(99.7 %id)
CD246189 mixed .c 899 to 1600 1 to 712       712/870
(81 %)
19 diff
(97.9 %id)
CN408698 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1063 to 1739 3 to 679       677/679
(99 %)
0 diff
(100 %id)
AL556571 placenta .c 1078 to 1669 1 to 589       589/589
(100 %)
19 diff
(96.8 %id)
AK302715 testis .d 1 to 1753 3 to 1755 exact tiling clone,   1755/1755
(100 %)
0 diff
(100 %id)
DC402062 testis .d 1 to 560 3 to 563       563/563
(100 %)
1 diff
(99.9 %id)
DB037504 testis .e 1 to 566 2 to 567   tiling clone, capped   566/570
(99 %)
3 diff
(99.5 %id)
DB337551 testis .e 1275 to 1799 525 to 1   tiling clone,   525/525
(100 %)
0 diff
(100 %id)
BI464818 testis .f 96 to 584 111 to 597 A117V E118K E119R G120D S121Q ... tiling clone,   597/597
(100 %)
11 diff
(98.2 %id)
BM560410 brain, medulla .g 1 to 1010 1 to 1018 exact tiling clone,   1018/1059
(96 %)
21 diff
(98.1 %id)
EG328081 pooled .h 1 to 256 256 to 1   tiling clone, Submitted on the opposite strand 256/336
(76 %)
1 diff
(99.8 %id)
EG328080 pooled .h 72 to 318 1 to 247   tiling clone,   247/248
(99 %)
3 diff
(98.8 %id)
CD657298 Embryonic Stem cells .i 1 to 756 12 to 759 V148S S149P L150A L151G A152N ... tiling clone,   748/813
(92 %)
20 diff
(97.6 %id)
DB021916 testis .j 1 to 548 2 to 549 exact tiling clone, capped   548/548
(100 %)
0 diff
(100 %id)
BP259823 heart .k 1 to 369 1 to 368 S23L K39* tiling clone,   368/578
(63 %)
9 diff
(98.5 %id)
AI050884 brain, glioblastoma (pooled) .l 1 to 110 110 to 1 exact tiling clone,   110/110
(100 %)
0 diff
(100 %id)
FN170491 breast carcinoma .m 1 to 103 103 to 0 K6R M7C Q8S Q9R K10R ... tiling clone, Submitted on the opposite strand 103/103
(100 %)
1 diff
(99.1 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI